Mother teaching daughter

Prioritizing Patient Affordability

Commitment to Patient Access and Affordability of Our Medicines

Our commitment to transparency extends beyond responsible launch pricing and limited price increases. We recognize that too many patients in the United States are struggling to afford their medications, and that is why we offer a suite of programs to address a range of patient needs.

In 2020, as the world faced the COVID-19 pandemic, Sanofi moved to protect patients and their families and ensure continued access to our existing medicines. The urgency to ensure patient access was clear, and meaningful action was needed to help the millions experiencing unexpected loss of income and health insurance.

To help those who have been impacted as a result of COVID-19, Sanofi introduced temporary changes to the patient assistance component of Sanofi Patient Connection. These changes will remain in place as long as patients continue to remain impacted by the pandemic. 

Every patient has unique circumstances. Sanofi has live support specialists at (800) 633-1610 to answer patients’ questions and help navigate their individual situations in an effort to find the best resources and programs to help lower their out-of-pocket costs.

 

2020 Patient Support: By The Numbers

1.9 million
# of times a Sanofi copay assistance card was used
$543 million
Patient savings from use of copay assistance programs
91,415
# of times Insulins Valyou Savings Program was used
$35 million
Patient savings from use of Insulins Valyou Savings Program
99,693
# of patients who received free medicine through patient assistance programs
$890 million
Value of medicine provided via patient assistance programs